Clinical Trial Update: Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

View source ↗

Summary

An observational registry update documenting treatment patterns in castration-resistant prostate cancer; the study sponsored by Sanofi has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Sanofi | Conditions: Prostatic Neoplasms | Status: TERMINATED